It is set to break 51 soon then to 57 pending good Q 4 results.... accumulate more now !

It is set to fall below IPO price of 27 Sen soon...so stay away from it ....

Time to accumulate, begin to rebound ....cumulative VWAP to date is at about 46.3

The rate of intangible assets was built up too fast with significant amount, something is fishy , avoid this stock for good

根据这两天的交易数据，它将会跌破 发收价 27 Sen, 大家要小心

Don't buy first, wait till the acquisition proposal has submitted to Bursa ...

对了！快跑 ...改天再来

大家慢慢观赏，看 108 伞兵 如何 让它反回 50 Sen ...😛

Not too long from now it will reach 72/73 , perhaps by next week

Yes, any price below 42 sen is a big bargain, don't miss it

Stay away from it first,wait until it has fallen below 25 Sen

This operator is so " kelam kebut " , stay away from it first, wait until the trading volume has subsided...

准备和她 “爱情长跑了 ” ！ 哈哈哈

见仁见智

Esos 和 warrants 都是 future options, 拥有者都不必预先掏钱出来，当股价上升，它们都能在同一个时候累积成长价值，也就是说，它们都是growth value accumulators, a tool that can be used to minimise dilution effect caused by any possible future equity placement out to other new shareholders if funds raising are needed for company expansions...

👆👆一个懂得在股价还低的时候，先送 Esos 给职员和 warrants 给现有的股东，就可知道他是个有谋略和能干大事的老板... Sunzen 的新老板也如此。

置于死地而后生...I think it will move towards 30/31 soon

@Chang Keit Siong, Round 1 (about 4 months ago), bought from 43.5 to 45, sold at 52...now Round 2 , bought from 40 to 37 and back to 41 ..this round we have also called in our " 108 伞兵 ” to join the game...

Soon it will drift down below IPO price of 25 ....

No worries, next week it will start to move towards 46

大家的 草船 有 借 到 箭 了 吗 ？

We have started collecting this morning from 40 and below

DCHCARE ,13 clinic valued at 19 million per clinic , earning about 740k per clinic ( based on IPO price of 25 Sen), I Bella , 2 clinic valued at 35 million per clinic , earning about 1.45 million per clinic ...which one is cheaper ? Calculate yourself ...

不用担心 DCHCARE 和 I Bella 目前都是空壳股公司，因此它们的 ROE 特别高，成长动力基因强，所以值钱，君不见目前它的 trading PE特别高 ！明白它的奥妙就在这儿吗 ？不懂就慢慢学习和观察吧 ！

Acquisition of I Bella is based on 2 perspectives, (a) To enhance the DCHCARE growth rate and momentum..(b) To turn a strong competitor into a team member (在兵法里，这可是最高境界的手段...Turn a strong enemy into one of own soldiers)

👆👆Esos 和 warrant 都是 免费的 option, 前者送给职员，後者送给股东，老板得益最大，因为他是高层又是大股东..市场反应大，卖压越强，可以把股价压得越低，因此Esos 和 warrant的转换价 就可以定在低价位...然而 DCHCARE 是一只有强大成长动力的股（根据过去几年的成长数据的推算），当股价逐年上升，Esos 和 warrant 就很值钱了！明白吗？

Unload more shares into the market, in order to suppress the share prices further down, so later we can have opportunities to buy DCHCARE WA at low price ......good strategy ? 哈哈哈

Those who knows how to comprehend the Q 3 reports are accumulating now

To eliminate competitors from the open market

Know how to read the financial reports ?

先制造恐慌，之後才 “ 草船借箭 ” ，兵法里 最奇妙的一招 ...哈哈哈， 这一招能打倒很多看图的技术派

Start collecting

Now it is the only 2023 IPO stock that has the up trend chart after our team visit on 22 September and 9 October respectively...

Reversal of trend is intact now..

We should see it breaks 60 sen soon..

中了有心人的 “ 草船借箭 ” 之计 ！不多久就会慢慢回升了 ！ 不需要再惊慌 ...

迹象显示...it is moving towards corner 30/31 soon

离突破 50 sen 的时机不远了！大家一起观赏吧

市场对它开始恐慌了！可以进行 “ 草船借箭 ” 了 ！哈哈哈

Yes, once 31 is broken, it will retrace to 26/27 there

This counter is quite similar to GLXT , it has no impetus for growth...skip it if you can

This stock has now stayed above cumulative VWAP to date at about 72.37, therefore it is set to go higher , we just watch for its progress together...

这只股 缺乏 成长 动力 的基因，因此这类股的生意模式在这年代是不值钱的..Skip !

This stock now has stayed above cumulative VWAP to-date at about 39.3 , and also above IPO price of 43, therefore it is set to go higher soon in line with its robust growth of both Revenue and profit that are driven by e-commerce online sales in Europe and North America...we witnessed together for its progress from now onwards...

有眼光和洞察力强的人记得继续收票，很快它就会到达 49/50 的角落 。

It is right timing now to give it a " kick " 哈哈哈

It is highly strategic and far-sighted for this type of potentially high growth stock to issue warrants to enable shareholders to accumulate growth value without up front cash...接下来 就得 看看 老板 够不够 聪明 了 ！

Stingray, the main impetus of growth of this stock came its " 电商 ” ,and many investors can't comprehend it ...they thought Synergy just like other furniture stocks ...

Johnchew5, you are rude, behave yourself first..

Stingray, strictly speaking, Synergy is not just a furniture stock , it is also an e-commerce stock “ 电商股 ”。